Genmab | Kontanter Og Tilsvarende

Cash And Equivalent Endring Dato
Almirall EUR 314.3M 73.65M 2024-03
Amarin USD 270.81M 37.82M 2023-09
Amgen USD 9.71B 1.24B 2024-03
AstraZeneca USD 4.87B 793M 2023-09
Bayer EUR 4.73B 1.18B 2024-03
BioMarin Pharmaceutical USD 747M 8.13M 2024-03
Exelixis USD 259.56M 137.3M 2024-03
Fresenius Medical Care EUR 1.15B 404.99M 2024-03
Galapagos EUR 73.37M 93.43M 2024-03
Genmab DKK 14.27B 3.4B 2023-09
GlaxoSmithKline GBP 2.79B 146M 2024-03
GN Store Nord DKK 1.22B 938M 2024-03
GRIFOLS EUR 529.58M 45.35M 2023-12
Hikma Pharmaceutical USD 1000K 22M 2022-12
Insmed USD 595.73M 113.35M 2024-03
Lonza CHF 1.7B 359M 2023-06
Merck EUR 2.22B 238M 2024-03
Regeneron Pharmaceuticals USD 2.6B 13.64B 2024-03
Roche Holding CHF 3.72B 1.27B 2023-06
UCB EUR 457M 442M 2023-06



Genmab Kontanter Og Tilsvarende - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.